Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

9 Items

per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  2. AR-A014418
    A3184 AR-A014418
     2 Citation
    Target: GSK-3
    Summary: GSK3β inhibitor, ATP-competitive and selective
      insoluble in EtOH; insoluble in H2O; ≥15.4 mg/mL
  3. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  4. Indirubin
    B3672 Indirubin
    Target: Cyclin-Dependent Kinases|GSK-3
    Summary: cyclin-dependent kinases and GSK-3β inhibitor
      insoluble in H2O; insoluble in H2O; insoluble in EtOH; ≥13.1 mg/mL
  5. AZD1080
    B1536 AZD1080
     1 Citation
    Target: GSK-3
    Summary: GSK3βinhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  6. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  7. CHIR-124
    A8394 CHIR-124
    Target: FLT3|GSK-3|Chk|PDGFR
    Summary: Chk1 inhibitor,novel and potent
      insoluble in H2O; ≥10.5 mg/mL
  8. CHIR-98014
    A8395 CHIR-98014
    Target: GSK-3
    Summary: GSK-3β inhibitor,selective and ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL
  9. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL

9 Items

per page